Latest News and Press Releases
Want to stay updated on the latest news?
-
NEW YORK, May 29, 2002 (PRIMEZONE) -- Dow Chemical's OPS(TM) (Operational-cashflow Per Share) was positive and its OPS/EPS ratio for its trailing twelve months hits a record high of 6.2 to 1....
-
NEW YORK, May 28, 2002 (PRIMEZONE) -- Sears' OPS(TM) (Operational-cashflow Per Share) was negative for its most recent quarter ended March 31, 2002. StockDiagnostics.com has downgraded Sears Roebuck...
-
NEW YORK, May 23, 2002 (PRIMEZONE) -- Avon Products' OPS (TM) (Operational-cashflow Per Share) was negative for its most recent quarter ended March 31, 2002 and StockDiagnostics.com has downgraded...
-
NEW YORK, May 22, 2002 (PRIMEZONE) -- StockDiagnostics.com announces that it has suspended its OPS Rating(TM) on Taser International, Inc. (Nasdaq:TASR) due to a diagnosis of The EPS Syndrome(TM). ...
-
NEW YORK, May 22, 2002 (PRIMEZONE) -- StockDiagnostics.com announces that it has suspended its OPS Rating(TM) on Natco Group, Inc. (NYSE:NTG) due to a diagnosis of The EPS Syndrome(TM). OPS(TM)...
-
NEW YORK, May 22, 2002 (PRIMEZONE) -- Kodak's trailing 12 months' OPS(TM) (Operational-cashflow Per Share) increases 75% to a five-year record and StockDiagnostics.com has upgraded Eastman Kodak...
-
NEW YORK, May 21, 2002 (PRIMEZONE) -- StockDiagnostics.com announces that it has upgraded Abbott Laboratories (NYSE:ABT) to an OPS (Operational-cashflow Per Share) Rating(TM) of "1" from a previous...
-
NEW YORK, May 21, 2002 (PRIMEZONE) -- StockDiagnostics.com announces that it has suspended its OPS Ratings(TM) on the following companies due to a diagnosis of The EPS Syndrome(TM). OPS Ratings on...
-
NEW YORK, May 21, 2002, (PRIMEZONE) -- StockDiagnostics.com announces that it has upgraded Amazon.com, Inc. (Nasdaq:AMZN), to an OPS Rating(SM) of "3" from a previous OPS Rating of "6." This...
-
NEW YORK, May 20, 2002 (PRIMEZONE) -- StockDiagnostics.com announces that it has suspended its OPS Ratings(SM) on the following companies due to a diagnosis of The EPS Syndrome. OPS Ratings on over...